全文获取类型
收费全文 | 125篇 |
免费 | 3篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 4篇 |
妇产科学 | 10篇 |
基础医学 | 4篇 |
口腔科学 | 3篇 |
临床医学 | 2篇 |
内科学 | 21篇 |
神经病学 | 36篇 |
外科学 | 27篇 |
预防医学 | 4篇 |
药学 | 3篇 |
肿瘤学 | 3篇 |
出版年
2020年 | 1篇 |
2018年 | 4篇 |
2016年 | 3篇 |
2015年 | 1篇 |
2014年 | 3篇 |
2013年 | 3篇 |
2012年 | 10篇 |
2011年 | 9篇 |
2010年 | 5篇 |
2009年 | 6篇 |
2008年 | 7篇 |
2007年 | 10篇 |
2006年 | 4篇 |
2005年 | 8篇 |
2004年 | 13篇 |
2003年 | 12篇 |
2002年 | 8篇 |
2001年 | 4篇 |
1999年 | 2篇 |
1997年 | 1篇 |
1992年 | 1篇 |
1991年 | 4篇 |
1990年 | 2篇 |
1986年 | 1篇 |
1985年 | 2篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1976年 | 1篇 |
1969年 | 2篇 |
排序方式: 共有130条查询结果,搜索用时 15 毫秒
71.
72.
Gorgone G Currò M Ferlazzo N Parisi G Parnetti L Belcastro V Tambasco N Rossi A Pisani F Calabresi P Ientile R Caccamo D 《Neuromolecular medicine》2012,14(1):84-90
There is evidence that increased homocysteine (Hcy) levels might accelerate dopaminergic cell death in Parkinson's disease (PD) through neurotoxic effects. Homocysteine neurotoxicity mainly relies on redox state alterations. The present work was aimed at investigating the relationships between plasma Hcy concentrations and percent content of oxidized versus total Coenzyme Q10 (%CoQ10) in 60 PD patients and 82 healthy subjects. Both groups were screened for plasma levels of Hcy, vitamin B12, folate, %CoQ10 and C677T methylenetetrahydrofolate reductase (MTHFR) gene polymorphism. The MTHFR TT677 mutated genotype was found more frequently in patients than in controls (p = 0.01). In a multivariate analysis, Hcy levels and %CoQ10 were associated with the case/control category (p < 0.0001), MTHFR genotype (p < 0.0001) and their interaction term (p = 0.0015), even after adjusting for age, sex, folate and vitamin B12. Patients carrying the TT677 genotype exhibited the highest values of Hcy and %CoQ10 (p < 0.0001). Structural equation modelling evidenced that the TT677 genotype and levodopa daily dose were independently and directly correlated with Hcy (p < 0.0001, and p = 0.003, respectively), which, in turn, showed a significant correlation (p < 0.0001) with the %CoQ10 in PD patients. Our results suggest that increased Hcy levels act as mediator of the systemic oxidative stress occurring in PD, and %CoQ10 determination might be regarded as a predictor of toxic Hcy effects. 相似文献
73.
Francesco Ciccia Antonina Accardo‐Palumbo AnnaRita Giardina Piera Di Maggio Alfonso Principato Michele Bombardieri Aroldo Rizzo Riccardo Alessandro Angelo Ferrante Simona Principe Sergio Peralta Francesco Conte Sandro Drago Antonio Craxì Giacomo De Leo Giovanni Triolo 《Arthritis \u0026amp; Rheumatology》2010,62(12):3625-3634
74.
Cupello A Bandini F Albano C Favale E Marchese R Scarrone S Trompetto C 《The International journal of neuroscience》2008,118(10):1460-1466
The aim of this research was to follow parallelly the clinical status of a patient and the dynamics of the serotonin transporter (SERT), a likely player in the effect of electroconvulsive treatment (ECT), a powerful tool against deep depression. A patient affected by major depression with catatonic features, not responding to pharmacological therapy, underwent ECT. Evaluations of the binding of labelled paroxetine to venous blood platelet SERT were parallel to the assessments of clinical improvements. The density of platelet SERT, starting from a low level before ECT, displayed an initial steep increase peaking the day after the third electroconvulsive session (5 days after the start of ECT). This was followed by a rapid decrease, which seemed to precede the process of clinical recovery. These results were found in a case of unavoidable ECT treatment. If generalizable, they suggest interesting ideas about the still mysterious mechanism of ECT antidepressant action. 相似文献
75.
Siquini W Macarri G Freddara U Stortoni P Ridolfo R Petrolati P Fianchini A Landi E 《Annali italiani di chirurgia》2007,78(1):31-37
The colorectal cancer presents with bowel obstruction in 10%-30% of patients. Established treatment of this evolutive condition, until 15 years ago, was emergency surgery. Primary resection with or without ileostomy, staged resection, Hartmann's procedure, or definitive colostomy are the therapeutical options. There is ongoing controversy on the best procedure to apply, because the choice depends on the patient's condition, age, electrolyte imbalances, nutritional status, obstructional grade, comorbidity and surgeon's attitude. However, the obstruction and the emergency operation add risk of complications and mortality instead of elective surgery. The efficacy of self-expanding metal stent to solve the obstruction had recently changed the management of malignant luminal obstruction: it is safe, effective, with very low mortality, low morbidity and also cheap. In the inoperable cases it represents the first line therapy avoiding the colostomy. In the operable patients, instead of two-step surgery, the SEMS had to be preferred because is a one-time and election surgery and avoid colostomy too, even if temporary. SEMS versus emergency primary surgery, without randomized and controlled study, allows a safer single-staged surgery. Finally it improves the quality of life avoiding colostomy, and reducing operative risk. We present two different use of SEMS: the palliation in inoperable patient and the "bridge to surgery" in critical obstructed patient. 相似文献
76.
77.
Olavo Mion Jo?o Ferreira de Mello Marcus Miranda Lessa Elder Yoshimitsu Goto Aroldo Miniti 《Otolaryngology--head and neck surgery》2003,128(1):27-31
OBJECTIVE: We investigated the role of allergic rhinitis in chronic otitis media (otitis media with effusion [OME] and chronic perforation of the tympanic membrane) in S?o Paulo, Brazil and whether there is any association between these diseases. STUDY DESIGN AND SETTING: We studied 51 patients followed in the otologic group of the Otorhinolaryngology Division of the University of S?o Paulo Hospital. The patients were divided into 3 groups: allergic rhinitis, nonallergic rhinitis with eosinophils syndrome (NARES), and patients with types of rhinitis or without rhinitis. We analyzed the age, gender, intensity of the nasal disease, surgical procedure, and surgical results in each group. RESULTS: We found about 50% of patients presenting with nasal disease and nasal eosinophilia (33.33% of allergic and 15.69% of NARES). CONCLUSION: Nasal disease has an impact on otologic middle ear disease, considering that the normal nasal mucosa do not have eosinophils. 相似文献
78.
Deferiprone versus deferoxamine in patients with thalassemia major: a randomized clinical trial 总被引:5,自引:0,他引:5
Maggio A D'Amico G Morabito A Capra M Ciaccio C Cianciulli P Di Gregorio F Garozzo G Malizia R Magnano C Mangiagli A Quarta G Rizzo M D'Ascola DG Rizzo A Midiri M 《Blood cells, molecules & diseases》2002,28(2):196-208
Deferiprone has been suggested as an effective oral chelation therapy for thalassemia major. To assess its clinical efficacy, we compared deferiprone with deferoxamine in a large multicenter randomized clinical trial. One-hundred forty-four consecutive patients with thalassemia major and serum ferritin between 1500 and 3000 ng/ml were randomly assigned to deferiprone (75 mg/kg/day) (n = 71) or deferoxamine (50 mg/kg/day) (n = 73) for 1 year. The main measure of efficacy was the reduction of serum ferritin. Liver and heart iron contents were assessed by magnetic resonance. Liver iron content and fibrosis stage variations were assessed on liver biopsy by the Ishak score in all patients willing to undergo liver biopsy before and after treatment. The mean serum ferritin reduction was 222 +/- 783 ng/ml in the deferiprone and 232 +/- 619 ng/ml in the deferoxamine group (P = 0.81). No difference in the reduction of liver and heart iron content was found by magnetic resonance between the two groups. Thirty-six patients accepted to undergo repeat liver biopsy: 21 in the deferiprone and 15 in the deferoxamine group. Their mean reduction of liver iron content was 1022 +/- 3511 microg/g of dry liver and 350 +/- 524, respectively (P = 0.4). No difference in variation of the Ishak fibrosis stage was observed between the two groups. Treatment was discontinued because of reversible side effects in 5 patients in the deferiprone group (3 hypertransamin/asemia and 2 leukocytopenia) and in none in the deferoxamine group. These findings suggest that deferiprone may be as effective as deferoxamine in the treatment of thalassemia major with few mild and reversible side effects. 相似文献
79.
80.